![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
TARGETING REPRODUCTIVE MEDICINE AND BEYOND
Minerva Ginecologica 2013 October;65(5):497-504
Copyright © 2013 EDIZIONI MINERVA MEDICA
language: English
Androgen supplementation in IVF
Kim C. H. ✉
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea
The desired objective of controlled ovarian stimulation (COS) is to allow the growth of a cohort of follicles and to facilitate the recovery of a large number of fertilizable oocytes. However, poor responders with diminished ovarian reserve often fail to respond adequately despite the maximal dose of gonadotropins administered, with the results that the number as well as quality of oocytes harvested may be very low, thereby decreasing the pregnancy rate in IVF cycles. Therefore, successful COS for poor responders remains to be a major challenge in IVF program. One of promising strategies for augmenting follicular recruitment in poor responders is androgen supplementation. However, there are limited data on androgen treatment for poor responders undergoing IVF. Therefore, well-designed larger studies with standardized methods are required.